Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic review

This systematic review assessed the long-term outcomes for patients treated with intravitreal antivascular endothelial growth factor or dexamethasone for macular oedema (MO) secondary to retinal vein occlusion (RVO). Studies investigating patients of all ages with MO due to RVO only were included. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunter, Alexandra, Williams, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198693/
https://www.ncbi.nlm.nih.gov/pubmed/36063388
http://dx.doi.org/10.1136/bmjophth-2022-001010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198693/
https://www.ncbi.nlm.nih.gov/pubmed/36063388
http://dx.doi.org/10.1136/bmjophth-2022-001010

Ejemplares similares